With concerns mounting and speculation swirling, the particulars of President Donald Trump’s much-touted “Liberation Day” ...
The second executive at a drugmaker said his company was "stockpiling" in the United States, the pharma industry's ...
Perhaps the Tuesday pharma sell-off was mitigated by indications Trump and his team might be amenable to either a softer or more gradual approach to industry tariffs. That bearishness about the ...
In recent years, the pharmaceutical landscape has witnessed a seismic shift as cannabinoids transition from niche alternatives to mainstream medical solutions.
Kennedy Jr., a longtime and visceral critic of pharmaceutical and biotech companies, was nominated by President Trump to be ...
Over a month into Robert F. Kennedy Jr.’s tenure as HHS Secretary, leaders in pharma, medical marketing and media circles are ...
14h
European healthcare stocks tumble as Trump prepares new tariffs, with pharmaceutical firms bracing for economic fallout and market uncertainty.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback